ALFA FinderNSE filing, NSE: JSLL. Summary written from the filing by ALFA Finder's alert engine.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹362.50
- Market cap
- ₹4,507 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 19.1×Sector 43.8×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Merger & Restructuring Worth ₹0.03 Cr
Jeena Sikho Lifecare's board approved incorporating Ayugenomics Private Limited as a subsidiary, holding 60%. The company will invest Rs 3 lakh, subject to statutory approvals.
- Value
- ₹0.03 Cr
Jeena Sikho Lifecare Board Meeting Date
Jeena Sikho Lifecare has scheduled a board meeting for 14 Nov 2026 to consider unaudited Q1 FY27 financial results. The trading window is closed from 1 Oct to 16 Nov 2026.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare allotted 23,374 equity shares under its ESOS 2024 scheme. This allotment increases the company's total paid-up equity share capital.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare Limited has launched eight new Ayurvedic healthcare, wellness, and nutraceutical products. These new offerings are now available in the domestic market.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare received NABH accreditation for its hospital in Raipur, Chhattisgarh, signifying adherence to quality healthcare and patient safety standards.
Other product launch announcements
All →HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.
AstraZeneca Pharma India Product Launch
AstraZeneca Pharma India will launch Datverzo, Datopotamab Deruxtecan, in India in November 2026. The drug holds DCGI import and market permission for HR-positive, HER2-negative breast cancer.
Raama Finance Product Launch
Raama Finance launched 'Rupya Lelo', a digital lending platform offering instant personal loans, on October 6, 2026. The product is available only in India, and no loan amount or financial figure is disclosed.
Puravankara Product Launch
Puravankara will launch the residential project Purva Cityspire Phases 1, 2 and 3 in Ernakulam on 15 November 2026. The project is RERA-registered and is being developed by two wholly owned subsidiaries.
JBM Auto Product Launch
JBM Electric Vehicles launched the all-electric ECOLIFE e12 city bus at Singapore Urban Mobility Week 2026. It cites 20,000-bus annual capacity and a new Singapore APAC hub.
- electric bus manufacturing capacity
- 20000.0 buses per annum